The insurance firm, The Progressive Corporation (PGR), garnered various analyst outlooks. BMO Capital raised their price target from $247 to $260, while maintaining a Market Perform rating, but also later downgraded at PGR stocks. Likewise, Barclays and Evercore ISI lowered their price target but retained an Equal Weight and Hold Rating respectively. Keefe, Bruyette & Woods raised its price target and kept a Market Perform Rating, although Morgan Stanley slashed their price target from $265 to $214.
PGR's stock performance has been underperforming the Dow and has seen a decrease in value. Despite this, the fundamental financials appear strong, offering potential for recovery. Q3 2025 Earnings had been in line with expectations, despite some margin concerns and PGR lagging behind in earnings and revenue estimates. Q3 also saw policy growth, though PGR showed a decline due to investor concerns.
Progressive's entry into the commercial insurance growth strategy was flagged with its partnership with Coterie. Moreover, PGR showed strong growth and was considered a good long-term value stock.
Progressive Corporation PGR News Analytics from Wed, 04 Jun 2025 07:00:00 GMT to Fri, 28 Nov 2025 07:19:00 GMT - Rating -3 - Innovation 2 - Information 5 - Rumor -4
